SeaStar Medical Holding Corp (ICU)
4.28
+0.22
(+5.42%)
USD |
NASDAQ |
Sep 27, 16:00
4.24
-0.04
(-0.93%)
After-Hours: 20:00
SeaStar Medical Research and Development Expense (Annual): 5.973M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.973M |
| December 31, 2022 | 2.503M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.766M |
| December 31, 2020 | 4.025M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
2.503M
Minimum
2022
5.973M
Maximum
2023
3.817M
Average
3.396M
Median
Research and Development Expense (Annual) Benchmarks
| Bolt Biotherapeutics Inc | 61.54M |
| CVS Health Corp | -- |
| Walgreens Boots Alliance Inc | -- |
| Nuwellis Inc | 5.422M |
| Verastem Inc | 61.36M |